Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

26.8%

19 terminated/withdrawn out of 71 trials

Success Rate

72.1%

-14.4% vs industry average

Late-Stage Pipeline

13%

9 trials in Phase 3/4

Results Transparency

39%

19 of 49 completed trials have results

Key Signals

19 with results13 terminated6 withdrawn

Enrollment Performance

Analytics

N/A

29(48.3%)

Phase 2

16(26.7%)

Phase 4

5(8.3%)

Phase 1

5(8.3%)

Phase 3

4(6.7%)

Early Phase 1

1(1.7%)

60Total

N/A(29)

Phase 2(16)

Phase 4(5)

Phase 1(5)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (71)

Showing 20 of 71 trials

NCT00580515Not ApplicableCompleted

Trial of Family Focused Grief Therapy in Palliative Care and Bereavement

Role: collaborator

NCT00953771Phase 2Terminated

Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)

Role: collaborator

NCT01186341Completed

BraveNet Multi-Center Study on Integrative Medicine Treatment Approaches for Pain

Role: collaborator

NCT04879797Not ApplicableUnknown

Reducing Racial Disparities in Severe Maternal Morbidity

Role: collaborator

NCT03321734Phase 2Completed

Intermittent Hypoxia and Caffeine in Infants Born Preterm

Role: collaborator

NCT02086630Phase 1Completed

Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline

Role: collaborator

NCT00593983Phase 2Completed

Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials (the ACT2 Project)

Role: collaborator

NCT02261558Not ApplicableCompleted

Effects of Clinical Music Improvisation on Resiliency in Adults Undergoing Infusion Therapy

Role: lead

NCT02430948Not ApplicableCompleted

Improving Compliance With Medical Testing Guidelines

Role: lead

NCT01760252Phase 2Terminated

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Role: lead

NCT00924807Phase 1Terminated

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Role: lead

NCT02019979Phase 2Terminated

Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)

Role: lead

NCT00529633Phase 3Terminated

The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients

Role: collaborator

NCT00831181Phase 2Completed

Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer

Role: lead

NCT00832299Phase 2Terminated

Neo-Adjuvant FOLFOX for Rectal Carcinoma

Role: lead

NCT02355080Phase 2Completed

A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results

Role: collaborator

NCT02436603Not ApplicableCompleted

Integrative Approaches to Managing Irritable Bowel Syndrome (IBS)

Role: lead

NCT00183209Not ApplicableCompleted

Interventions for HIV+ Mothers With Problem Drinking

Role: collaborator

NCT00142506Phase 3Completed

Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

Role: collaborator

NCT03276364Completed

The Impact of Point-of-Care Ultrasound

Role: collaborator